VGH Solutions Feels Pain In US Review For Basing OTC Device Ad Claims On Canada’s Approval
Executive Summary
NAD advises VGH Solutions to pull pain relief claims and statements that am OTC device with FDA 510(k) clearance treats conditions including neuropathy. The firm offered studies and a Health Canada statement listing indications for the device to support claims not part of the US approved indication.